NCT02778113 - A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

November 30, 2011

Conditions

Healthy

Interventions

DRUG

Nasal Glucagon

Administered intranasally.

DRUG

Glucagon

Administered SC.

Trial Locations (1)

H3P 3P1

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mount Royal